Related Experiment Video
Updated: Dec 3, 2025
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible
Salvatore D'Agate1, Flora Tshinanu Musuamba1, Oscar Della Pasqua1
1Clinical Pharmacology and Therapeutics Group, University College London, London, United Kingdom.
Insights
Simplified amoxicillin dosing for infants with sepsis is feasible using pharmacokinetic-pharmacodynamic principles. This approach accounts for growth, maturation, and sepsis, offering a more robust guidance than current empirical methods.
Area of Science:
- Pharmacology
- Pediatrics
- Infectious Diseases
Background:
- Amoxicillin dosing in young children often relies on empirical data, especially in resource-limited settings.
- Understanding pharmacokinetic variability is crucial for developing effective, simplified dosing regimens.
- Factors like growth, renal maturation, and disease influence amoxicillin exposure.
Purpose of the Study:
- To propose a simplified amoxicillin dosing regimen for neonates and young infants with sepsis.
- To utilize pharmacokinetic-pharmacodynamic principles for regimen design.
- To account for developmental and disease-related factors affecting drug exposure.
Main Methods:
- A meta-analytical modeling approach adapted an existing pharmacokinetic model for amoxicillin.
- Allometric concepts and a maturation function were used for model parameterization.
- Clinical trial simulations assessed exposure (AUC, Cmax, Cmin, T>MIC) to maximize time above minimum inhibitory concentration (T>MIC).
Main Results:
- A two-compartment model best described amoxicillin pharmacokinetics.
- Sepsis was found to alter amoxicillin distribution, lowering levels and increasing half-life.
- A simplified fixed-dose regimen was proposed: 125 mg twice daily for <4.0 kg and 250 mg twice daily for ≥4.0 kg.
Conclusions:
- Sepsis, developmental growth, and renal maturation significantly alter amoxicillin disposition.
- A model-based approach effectively integrated these factors for dose rationale.
- Simplified weight-banded dosing for infants with sepsis is recommended when referral is not possible.
Background:
Despite the widespread use of amoxicillin in young children, efforts to establish the feasibility of simplified dosing regimens in resource-limited settings have relied upon empirical evidence of efficacy. Given the antibacterial profile of beta-lactams, understanding of the determinants of pharmacokinetic variability may provide a more robust guidance for the selection of a suitable regimen. Here we propose a simplified dosing regimen based on pharmacokinetic-pharmacodynamic principles, taking into account the impact of growth, renal maturation and disease processes on the systemic exposure to amoxicillin.
Materials And Methods:
A meta-analytical modeling approach was applied to allow the adaptation of an existing pharmacokinetic model for amoxicillin in critically ill adults. Model parameterization was based on allometric concepts, including a maturation function. Clinical trial simulations were then performed to characterize exposure, as defined by secondary pharmacokinetic parameters (AUC, Cmax, Cmin) and T>MIC. The maximization of the T>MIC was used as criterion for the purpose of this analysis and results compared to current WHO guidelines.
Results:
A two-compartment model with first order absorption and elimination was found to best describe the pharmacokinetics of amoxicillin in the target population. In addition to the changes in clearance and volume distribution associated with demographic covariates, our results show that sepsis alters drug distribution, leading to lower amoxicillin levels and longer half-life as compared to non-systemic disease conditions. In contrast to the current WHO guidelines, our analysis reveals that amoxicillin can be used as a fixed dose regimen including two weight bands: 125 mg b.i.d. for patients with body weight < 4.0 kg and 250 mg b.i.d. for patients with body weight ≥ 4.0 kg.
Conclusions:
In addition to the effect of developmental growth and renal maturation, sepsis also alters drug disposition. The use of a model-based approach enabled the integration of these factors when defining the dose rationale for amoxicillin. A simplified weight-banded dosing regimen should be considered for neonates and young infants with sepsis when referral is not possible.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:29Drug Dosing: Infants and Children
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:21Factors Affecting Drug Response: Overview
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution